These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11355589)

  • 21. Protective effect of amifostine on dental health after radiotherapy of the head and neck.
    Rudat V; Meyer J; Momm F; Bendel M; Henke M; Strnad V; Grötz K; Schulte A
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1339-43. PubMed ID: 11121631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma.
    Bourhis J; Rosine D
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):61-2. PubMed ID: 12577247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemoradiotherapy for head and neck cancer: 'local' side effects are actually systemic.
    J Support Oncol; 2006 Feb; 4(2):88. PubMed ID: 16499131
    [No Abstract]   [Full Text] [Related]  

  • 24. Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection?
    Vacha P; Fehlauer F; Mahlmann B; Marx M; Hinke A; Sommer K; Richter E; Feyerabend T
    Strahlenther Onkol; 2003 Jun; 179(6):385-9. PubMed ID: 12789464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer.
    Anné PR
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):80-3. PubMed ID: 12577250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis.
    Sasse AD; Clark LG; Sasse EC; Clark OA
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):784-91. PubMed ID: 16198504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Side effects of postoperative radiochemotherapy with amifostine versus radiochemotherapy alone in head and neck tumors. Preliminary results of a prospective randomized trial].
    Vacha P; Marx M; Engel A; Richter E; Feyerabend T
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():18-22. PubMed ID: 10584135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical evaluation of sodium alginate on oral mucositis associated with radiotherapy].
    Oshitani T; Okada K; Kushima T; Suematsu T; Obayashi K; Hirata Y; Takada Y; Ishida T; Yoshida M; Narabayashi I
    Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1129-37. PubMed ID: 2398298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study.
    Makkonen TA; Boström P; Vilja P; Joensuu H
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):177-82. PubMed ID: 8083112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: a preliminary report.
    Nicolatou O; Sotiropoulou-Lontou A; Skarlatos J; Kyprianou K; Kolitsi G; Dardoufas K
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):551-6. PubMed ID: 9806514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sucralfate in the prevention of radiation-induced oral mucositis.
    Cengiz M; Ozyar E; Oztürk D; Akyol F; Atahan IL; Hayran M
    J Clin Gastroenterol; 1999 Jan; 28(1):40-3. PubMed ID: 9916664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tools for optimal tissue sparing in concomitant chemoradiation of advanced head and neck cancer: subcutaneous amifostine and computed tomography-based target delineation.
    Braaksma M; Levendag P
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):63-70. PubMed ID: 12577248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manifestations and treatment of xerostomia and associated oral effects secondary to head and neck radiation therapy.
    Garg AK; Malo M
    J Am Dent Assoc; 1997 Aug; 128(8):1128-33. PubMed ID: 9260423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
    Thorstad WL; Chao KS; Haughey B
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and histopathological evaluation of sucralfate in prevention of oral mucositis induced by radiation therapy in patients with head and neck malignancies.
    Etiz D; Erkal HS; Serin M; Küçük B; Hepari A; Elhan AH; Tulunay O; Cakmak A
    Oral Oncol; 2000 Jan; 36(1):116-20. PubMed ID: 10889930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary data of the GORTEC 2000-02 phase III trial comparing intravenous and subcutaneous administration of amifostine for head and neck tumors treated by external radiotherapy.
    Bardet E; Martin L; Calais G; Tuchais C; Bourhis J; Rhein B; Feham N; Alphonsi M
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):57-60. PubMed ID: 12577246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data.
    Bourhis J; Blanchard P; Maillard E; Brizel DM; Movsas B; Buentzel J; Langendijk JA; Komaki R; Swan Leong S; Levendag P; Pignon JP
    J Clin Oncol; 2011 Jun; 29(18):2590-7. PubMed ID: 21576630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized double-blind trial of amifostine versus placebo for radiation-induced xerostomia in patients with head and neck cancer.
    Lee MG; Freeman AR; Roos DE; Milner AD; Borg MF
    J Med Imaging Radiat Oncol; 2019 Feb; 63(1):142-150. PubMed ID: 30461207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amifostine in the management of radiation-induced and chemo-induced mucositis.
    Bensadoun RJ; Schubert MM; Lalla RV; Keefe D
    Support Care Cancer; 2006 Jun; 14(6):566-72. PubMed ID: 16586122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Radioprotective effects on head and neck tumors of amifostine--a broad-spectrum cytoprotection].
    Huang R; Yu H; Kuang A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Dec; 19(4):708-11. PubMed ID: 12561384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.